Form D · Other
Rapid Therapeutic Science Laboratories, Inc.
Dallas, TX · CIK 0001575659
Offering snapshot reported Feb 4, 2021 · SEC filing
- Reported sold
- $500K Offering amount: $1.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Jan 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 4, 2021 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 7, 2020 | Initial | $377,500 | No comparison | 8 | SEC filing |
| Dec 7, 2020 | Initial | $1,270,000 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388379
Source: Form D, filed Feb 4, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donal R. Schmidt | Director, Executive |
| D. Hughes Watler | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
5580 Peterson Lane Suite 200
Dallas, TX, 75240
Dallas, TX, 75240